trending Market Intelligence /marketintelligence/en/news-insights/trending/R6YiVsHW5fHIs9TIZ4-aKA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Medtronic closes acquisition of software company Klue

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Medtronic closes acquisition of software company Klue

Medtronic PLC has closed the acquisition of software company Klue, which will add new technology for use in the medical-device maker's automated insulin pump system.

The personalized closed loop pump system automates insulin delivery in patients. Medtronic intends to use Klue's technology to give real-time insights into a person's food consumption so that the PCL system can adapt to users in real-time. The technology will also be used in Medtronic's glucose management system to schedule patients' doses.

Medtronic's PCL system, several models of which were recalled in June due to cybersecurity vulnerabilities, won a breakthrough designation from the U.S. Food and Drug Administration in February.

Financial details of the acquisition were not disclosed in a Dec. 17 press release announcing the deal's closure.

Dublin-based Medtronic develops and distributes device-based medical therapies to hospitals, physicians, clinicians and patients.